BUSINESSTHE RIO TIMES
Oncoclínicas Debt Crisis Deepens as Goldman Sachs Exits
Brazil's largest cancer-treatment network Oncoclínicas is seeking an out-of-court debt deal as its oldest institutional investor, Goldman Sachs, exits, escalating concerns for creditors and patients.
Related Signal
Adjacent reporting
- Brazil’s Oncoclínicas Nears a Debt Reckoning as Cash Runs Short
- Brazil’s Oncoclinicas to File for Creditor Protection on Monday
- Brazil’s Cancer Giant Has $24m in Cash and $680m Due This Year
- Brazil’s Oncoclinicas Said to File for Out-of-Court Debt Rework
- Brazil’s Central Bank Wades Into the Ambipar Fight to Protect Hedging